New advice to limit the use of nasal decongestant sprays containing xylometazoline and oxymetazoline to a maximum of […]
Category: Respiratory medicine
The launch is part of the NIHRs £42m funding to establish 14 new HRCs across England
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) is investigating the risks associated with montelukast, which is […]